BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22113254)

  • 1. Twenty-five year results of the national cancer institute randomized breast conservation trial.
    Simone NL; Dan T; Shih J; Smith SL; Sciuto L; Lita E; Lippman ME; Glatstein E; Swain SM; Danforth DN; Camphausen K
    Breast Cancer Res Treat; 2012 Feb; 132(1):197-203. PubMed ID: 22113254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
    Poggi MM; Danforth DN; Sciuto LC; Smith SL; Steinberg SM; Liewehr DJ; Menard C; Lippman ME; Lichter AS; Altemus RM
    Cancer; 2003 Aug; 98(4):697-702. PubMed ID: 12910512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
    Litière S; Werutsky G; Fentiman IS; Rutgers E; Christiaens MR; Van Limbergen E; Baaijens MH; Bogaerts J; Bartelink H
    Lancet Oncol; 2012 Apr; 13(4):412-9. PubMed ID: 22373563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast conserving therapy in stage I & II breast cancer in Korea.
    Lee HD; Yoon DS; Koo JY; Suh CO; Jung WH; Oh KK
    Breast Cancer Res Treat; 1997 Jul; 44(3):193-9. PubMed ID: 9266098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial.
    Brooks JP; Danforth DN; Albert P; Sciuto LC; Smith SL; Camphausen KA; Poggi MM
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):785-9. PubMed ID: 15936560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
    Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes among breast cancer patients with extensive regional lymph node involvement: implications for locoregional management.
    Braunstein LZ; Galland-Girodet S; Goldberg S; Warren LE; Sadek BT; Shenouda MN; Abi-Raad RF; MacDonald SM; Taghian AG
    Breast Cancer Res Treat; 2015 Dec; 154(3):633-9. PubMed ID: 26585579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
    van Dongen JA; Voogd AC; Fentiman IS; Legrand C; Sylvester RJ; Tong D; van der Schueren E; Helle PA; van Zijl K; Bartelink H
    J Natl Cancer Inst; 2000 Jul; 92(14):1143-50. PubMed ID: 10904087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is mastectomy superior to breast-conserving treatment for young women?
    Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
    van Dongen JA; Bartelink H; Fentiman IS; Lerut T; Mignolet F; Olthuis G; van der Schueren E; Sylvester R; Tong D; Winter J
    Eur J Cancer; 1992; 28A(4-5):801-5. PubMed ID: 1524898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
    Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
    JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the National Cancer Institute early breast cancer trial.
    Straus K; Lichter A; Lippman M; Danforth D; Swain S; Cowan K; deMoss E; MacDonald H; Steinberg S; d'Angelo T
    J Natl Cancer Inst Monogr; 1992; (11):27-32. PubMed ID: 1627428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
    Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
    J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast conservative therapy in east part of China: a retrospective cohort study.
    Fan J; Wang L; Wang XJ; Wu J; Lu JS; Di GH; Shen KW; Han QX; Liu BL; Shen ZZ; Shao ZM
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):573-8. PubMed ID: 16741727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of breast-conserving therapy for younger women with breast cancer.
    Guenther JM; Kirgan DM; Giuliano AE
    Arch Surg; 1996 Jun; 131(6):632-6. PubMed ID: 8645070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.
    Jacobson JA; Danforth DN; Cowan KH; d'Angelo T; Steinberg SM; Pierce L; Lippman ME; Lichter AS; Glatstein E; Okunieff P
    N Engl J Med; 1995 Apr; 332(14):907-11. PubMed ID: 7877647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.